The Organisation of Pharmaceutical Producers of India (OPPI), which represents global research-based pharmaceutical companies, has appointed Anil Matai as its Director General (DG).
Matai, a seasoned general management professional, has extensive experience in the life sciences space having worked across MNCs including spearheading operations across Novartis India, GSK India, and Global Pharma, Dubai.
After superannuating as Managing Director of Zydus Healthcare, Matai was engaged as Senior Advisor - Life Sciences at IQVIA Consulting and Information Services India, and most recently as Operating Partner at Jashvik Capital - a mid-market Private Equity Fund focused on Healthcare & Consumer sector.
He has functioned on the boards of Zydus Healthcare, Bayer Zydus Pharma, Novartis Healthcare and Biochem Pharmaceutical Industries.
As an influential leader, his proven skillsets in operations leadership, collaborative working, stakeholder management, have contributed towards market-leading results. He has championed multi-million-dollar businesses and is proficient in unlocking company value by successfully executing growth strategies, institutionalising controls, and enhancing productivity.
